Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitroAlejandro Ibáñez‐Costa, Justo P. Castaño, Alfonso Soto‐Moreno et al.|Journal of Endocrinology|2016Cited by 74
In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive featuresAlejandro Ibáñez‐Costa, Raúl M. Luque, Manuel D. Gahete et al.|Scientific Reports|2015Cited by 60
BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomasAlejandro Ibáñez‐Costa, Raúl M. Luque, Laura M. López‐Sánchez et al.|Scientific Reports|2017Cited by 32
Somatotropinomas, But Not Nonfunctioning Pituitary Adenomas, Maintain a Functional Apoptotic RET/Pit1/ARF/p53 Pathway That Is Blocked by Excess GDNFEsther Díaz‐Rodriguez, Clara V. Álvarez, Ángela R. Garcia-Rendueles et al.|Endocrinology|2014Cited by 14
The dopastatin BIM-23A760 distinctly influences key functional endpoints in different types of pituitary adenomas and normal pituitaries: role of somatostatin and dopamine receptor profileJusto P. Castaño, Raúl M. Luque, Alejandro Ibáñez‐Costa et al.|Endocrine Abstracts|2015Cited by 0